Arcutis Biotherapeutics, Inc.

ARQT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$25.94-3.43%

2026-08-03

Financials

Valuation Metrics

Arcutis Biotherapeutics, Inc.'s Market Cap is $3.24B. At end of 2025 it was $3.72B. Ranked #1674 of 3,111 in US market (top 54%), #597 of 1,445 on NASDAQ (top 41%), #99 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 37%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$3.24B	US#1,674/3,111 Sec#99/269
Revenue	$416M	US#2,440/3,111 Sec#88/269
Net Income	$-2M	US—/3,111 Sec—/269
Total Assets	$460M	US#2,785/3,111 Sec#171/269
Net Assets	$190M	US#2,756/3,111 Sec#202/269
Value
P/B	17.11x	US#2,791/3,111 Sec#232/269
P/S	7.81x	US#2,581/3,111 Sec#112/269
EV/EBITDA	214.47x	US#2,482/3,111 Sec#86/269
FCF Yield	0.83%	US#2,161/3,111 Sec#80/269
Profitability
ROE	-1.25%	US#2,204/3,111 Sec#77/269
ROA	-0.52%	US#2,264/3,111 Sec#77/269
Op. Margin	0.77%	US#2,387/3,111 Sec#85/269
Revenue Growth	60.07%	US#246/3,111 Sec#48/269
Financial Health
Debt Ratio	142.56%	US#1,445/3,111 Sec#185/269
Total Debt	$13M	US#2,782/3,111 Sec#193/269
FCF	$27M	US#2,103/3,111 Sec#75/269
Cash	$35M	US#2,729/3,111 Sec#248/269
Current Ratio	2.68x	US#919/3,111 Sec#204/269
Net Debt/EBITDA	-1.43x	US#245/3,111 Sec#19/269
Performance
1Y Return	81.53%	US#386/3,111 Sec#92/269
1M Return	0.50%	US#992/3,111 Sec#64/269
From 52W High	-18.35%	US#1,381/3,111 Sec#90/269
1Y MDD	-37.50%	US#1,831/3,111 Sec#134/269
Trading
Volume	1,536,945 shares	US#1,071/3,111 Sec#100/269
Trading Value	$40M	US#1,485/3,111 Sec#94/269
Per Share
EPS	$-0.13	US—/3,111 Sec—/269
BPS	$1.48	US#2,573/3,111 Sec#187/269